Golden
Sphere Fluidics

Sphere Fluidics

Company commercializing single cell analysis systems

Sphere Fluidics is a privately held company based in Babraham, Cambridge, UK that commercializes single cell analysis systems. The company was originally spun out from the University of Cambridge and has 32 patented products including, instruments, software, biochips, and specialist chemicals.



Sphere Fluidics' main products are Cyto-Mine and ESI-Mine. Cyto-Mine was introduced in September 2018. It is an automated platform which integrates single cell screening, sorting, isolation, and clone verification. The product is meant to work alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows. ESI-Mine is a platform that can be used for high-throughput mass spectometry (MS) analysis. It enables the retrieval of living copies of hits that are normally destroyed during MS procedures. 

Timeline

People

Name
Role
Related Golden topics

Andrew Mackintosh

Employee



Craig Cardella

Sales and Marketing Director, North America



Frank F. Craig

Director & CEO



John Mayfield

Finance Director



Marian Rehak

VP, Research and Development



Matthew Dunne

Global Distribution Manager



Paul Mears

Investor



Rob Marchmont

VP, Sales and Marketing



Rob Treanor

Director of Operations



Robert Walsh

Investor



Serena Davoli

Employee



Further reading

Title
Author
Link
Type







Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References